CryoFlux Technologies, Inc.
President and CEO
Gregory Noland Deeter did not invent CryoFlux. He found it. Thread by thread. Signal by signal. Across five decades and seven ventures on five continents.
The forensic equipment investigator who spent years tracing the physics of failure. The USAF telecom engineer who learned that signals travel through unexpected pathways. The systems analyst who noticed patterns that others declared unrelated. The founder who kept pulling threads that others misunderstood.
On February 27, 2026, the threads converged. What emerged was not a product. It was a governance architecture. 142+ USPTO provisional patent applications filed and growing. Entirely funded from personal resources. No institutional capital. No prior venture backing. No university affiliation.
The methodology behind the portfolio has a name. Synthagence™ is the cross-domain synthesis discipline that traces governing patterns across unrelated systems and identifies where they converge into a single architecture.
Biology taught the reactor chamber. Telecommunications taught the signal chain. Forensic investigation taught the evidence standard. Industrial systems taught the failure mode. Atmospheric physics taught the harvest principle. Cold governance was always the destination. Synthagence was the path.
THREAD PULLED. PATTERN FOUND. ARCHITECTURE REVEALED.
Every lane is an ungoverned thermal frontier. Cold Authority arrives with the same governing architecture applied to each one. Click any lane to see the problem it solves and the CryoFlux response.
Governed compute racks. CDaaS metered billing. Closed-loop LN2. Zero consumable loss.
CB-1 cold head governance retrofit. 0.0% boil-off. 99.98% recovery. 40,000+ systems.
Governed cold chain platform above all transport devices. Chain of custody that never breaks.
On-site LN2 and LOX generation for supply chain independence.
Governed superconducting systems for naval and defense infrastructure. SBA VOSB registered.
Retrofit doctrine. CryoFlux governance applied to existing HVAC infrastructure.
Precision governed cold delivery at the clinical interface. Human-scale thermal governance.
Seven architecture families. One governing body. Every organ connects to every other through the central governance core. The architecture is alive.
The Cold Engine. Generates, delivers, and recovers liquid nitrogen in a closed loop. Every other organ is downstream of its operation.
The governance decision layer. Consequence-weighted responses to thermal events across the full distribution network.
Atmospheric eviction doctrine made physical. Every point where atmosphere can enter, CryoFence removes it before cold arrives.
The thermal conditioning organ. Precision-governed chambers that establish and maintain cryogenic state at the point of application with zero thermal degradation.
The conditioned distribution architecture. Multi-conduit armored pathways that maintain fluid state from source to thermal frontier.
On-site LN2 and LOX generation for supply chain independence.
Thermal state preservation across distribution distance. Cold quality at the frontier matches cold quality at the source.
Not a showroom. A live, instrumented, multi-application demonstration facility. Every system CryoFlux has designed, patented, and built performs in real time, in front of the people who will decide to license it. The LOI is not generated by a slide. It is generated by what a visitor watches operating in this room.
Governed compute cluster with live CDaaS billing telemetry and thermal floor monitoring.
Full HVAC loop demonstration with live thermal imaging. Frost formation visible in real time.
CB-1 retrofit architecture. Live vapor capture metrics. VitalChain organ transport exhibit.
CryoPhase Harvester operating live. Atmospheric generation with real-time yield metrics.
CryoBerth plinth. Any compatible appliance plugs in, seats, NFC registers, reports immediately.
"ARM Holdings licensed a chip architecture and became a $100 billion company without manufacturing a single chip. CryoFlux licenses a cryogenic governance architecture. Dell, GE Healthcare, Linde, and the hyperscalers are not the competition. They are the licensees."Gregory Noland Deeter, President and CEO, CryoFlux Technologies, Inc.
ARM Holdings plc. performance data sourced from public filings, SoftBank Group Corp. Annual Report, and ARM Ltd. corporate disclosures. NASDAQ: ARM. CryoFlux revenue architecture is a projected parallel, not a guarantee of equivalent performance.
CryoFlux does not build the cold. CryoFlux is the Cold Authority that governs cold everywhere it exists across the thermal frontier. Three revenue streams from every licensed deployment. Architecture licensing scales without proportional headcount.
CryoFlux licenses the build specifications. Manufacturers align with CryoFlux to build to our exacting quality standards. Our certified manufacturing partners are participants in the cold chain of CryoFlux Architecture. The architecture is the product. Access to it is a badge of honor.
Billed centrally against CryoCoordination Informatics™ telemetry. Every governed deployment in the field reports. Revenue sharing flows on every unit of cold governed under license to CryoFlux. Every report is a billing event.
The platform fee covers telemetry, health scoring, service alerts, billing data generation, and compliance reporting. The intelligence layer that secures compliance and ensures continuity for streams one and two.
Sole inventor. Micro Entity. Nine genus and meta-genus claims construct an eight-axis claim boundary. A competitor must simultaneously avoid all eight independent axes to operate outside the CryoFlux claim space. The portfolio is an active, growing body of work. CryoWorx Innovation Lab continues generating new governance architecture across all seven commercial lanes. The portfolio is not a promise of what will be built. It is evidence of what has already been done.
CryoFlux is establishing the Cold Governing Authority. The institutional standard by which cryogenic thermal energy is governed everywhere it exists.
We seek partners of conviction. If the platform speaks to you, reach out through the contact below. Vision before return. Integrity before terms. Alignment before capital.
CryoFlux Technologies, Inc. does not solicit securities publicly.
Conversations are confidential. | Accredited investors only. | Vision before return. Alignment before capital.
142+ provisional applications filed. 88 active development days to initial corpus completion. 685 documented hours. Every session timestamped. Every dollar sourced to a bank statement. The portfolio is forensically reconstructed from primary sources.
CryoFlux Technologies, LLC founded. No institutional capital. No university affiliation. No employer sponsorship. The work began on a fixed income with personal credit and total commitment to the signal that had been forming for fifty years.
142 provisional patent applications across seven commercial lanes. Sole inventor. Each application carries inline citation markers, a Claims section, and a Citation Index. Cold and Calculated Doctrine: citation is a character and good-faith force multiplier.
PKH engagement executed May 9, 2026. Retainer paid. Three prosecution bundles staged: Genus (~20 applications), Species (~50 applications), Application (~70 applications). NP deadlines begin March 2027.
CryoFlux Technologies, Inc. incorporated in Delaware. EIN 42-2761300. CAGE 1APJ0. SAM.gov UEI J1LKQT3VJFM9. SBA VOSB Application 87748. The institutional foundation is complete.
ATS NDT flow characterization of CTP-M PEEK test article. Gamma constant 0.16 confirmation. Gates UDT CTP-M build commitment. Every capital dollar downstream of this validation is protected by it.
"Deliver Cold in Its Best Possible State." Cold is not absence. Cold is potential. Governed. The portfolio is not a promise of what will be built. It is evidence of what has already been done.
Cryogenic thermal governance is the architecture of possibility.
Investor Inquiry
Request the full investor data room including the Seed SAFE Deal Sheet, CryoWorx Lab Strategic Brief, CDaaS 10-Year Revenue Model, Founder Investment Statement, and USPTO Filing Ledger.
Licensing and Partnership
Enterprise licensees, strategic partners, and fabricators interested in the ARM licensing model and the CryoWorx Innovation Lab demonstration program.